Protagenic Therapeutics, Inc. (PTIX) analyst actions
Rating and price-target actions on PTIX in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the PTIX overview →
1 measured PTIX analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market | Press release | +0.00% | +8.91% |
Keep exploring
More PTIX: earnings → · SEC filings → · PTIX overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| ZIVO BIOSCIENCE INC (ZIVO) | 122 | 0.00% | 29% |
| American Shared Hospital Services (AMS) | 121 | 0.00% | 48% |
| Xenetic Biosciences, Inc. (XBIO) | 121 | 0.00% | 38% |
| Avenue Therapeutics, Inc. (ATXI) | 120 | 0.00% | 37% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.